Mechanisms of Immunosuppression - Holland-Frei Cancer Medicine - NCBI Bookshelf
There is ample evidence that tumor cells produce immunosuppressive factors, and this has been verified to have local as well as systemic effects on immune function. In this section, we will discuss some of the better documented immunosuppressive factors released by tumor cells, their effects on immune function, and some strategies for therapeutic intervention based upon limiting the degree of immunosuppression associated with these molecules.
Mechanisms of Immunosuppression - Holland-Frei Cancer Medicine - NCBI Bookshelf The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Bookshelf Search database Books All Databases Assembly Biocollections BioProject BioSample Books ClinVar Conserved
related reading
- Glycosphingolipid synthesis mediates immune evasion in KRAS-driven cancernature.com
- Immunotherapy for Cancer - NCIcancer.gov
- UGCG and the glycosphingolipid rheostat: a metabolic checkpoint governing immune activation and tumor immune evasion | Signal Transduction and Targeted Therapynature.com
- Cancer cells educate natural killer cells to a metastasis-promoting cell state - PubMedpubmed.ncbi.nlm.nih.gov
- Cancer cells educate natural killer cells to a metastasis-promoting cell state - PMCpmc.ncbi.nlm.nih.gov
- Lopez-Colon.pdffredhutch.org
- Immune Regulation | People | Osaka University Immunology Frontier Research Centerifrec.osaka-u.ac.jp
- Immunotherapy in pediatric malignancies: current status and future perspectives - PMCncbi.nlm.nih.gov
- Publications - O'Sullivan labosullivanlab.com
- A body–brain circuit that regulates body inflammatory responsesnature.com
- Targeting UGCG overcomes resistance to lysosomal autophagy inhibitionpmc.ncbi.nlm.nih.gov
- Targeting telomerase for cancer therapy | Oncogenenature.com